Introduction
Endotracheal intubation without preceding analgosedation, is painful and associated with acute increases in blood pressure and intracranial pressure, bradycardia and hypoxia 1, 2 , and may cause neurological complications. 3 Current recommendations indicate that elective and semi-urgent intubations in infants should be performed after premedication. 4, 5 .However, no evidence-based consensus is available and treatment strategies vary.
Morphine is used as analgetic before intubation despite the slow onset and long duration of action 5 .
The benefits of muscle relaxants were reported in 1989 6 and later verified in a randomized controlled 9 Optimal premedication should eliminate pain, discomfort and physiological instability, and provide conditions for rapid and safe intubation without adverse effects. This can be achieved with a combination of drugs administered as a "rapid sequence induction/intubation" (RSI) which includes a vagolytic agent to prevent bradycardia and airway secretion, sedative and analgesic drugs to assure depressed consciousness and pain control and a muscle relaxant to suppress muscular activity. 5, 10 With increasing use of nasal continuous positive airway pressure (nCPAP) in preterm infants, instillation of surfactant should preferably be given by the INSURE (INtubate, Surfactant, Extubate) procedure, 11 for which a short-acting RSI would be optimal. A RSI regimen is also useful when prolonged mechanical ventilation is needed.
Sick preterm infants need intensive care during a period of a rapidly developing and highly vulnerable central nervous system and an immature hemodynamic state. Most analgesic and sedative drugs cause arterial hypotension and have potentially compromising cerebral side-effects. [12] [13] [14] [15] These drug effects can be detected using bedside monitoring technologies, such as near-infrared spectroscopy (NIRS) 16 and amplitude-integrated electroencephalogram (aEEG). 17, 18 Our aim was to develop a RSI premedication for preterm infants, and compare this to traditional morphine use in a RCT with special focus on the intubation procedure, stress/pain and need for additional analgesics, and potential short-term adverse events. The RSI was designed when very few premedication RCTs had been published, 1, [7] [8] [9] and the selected drugs were all short-acting and previously used in newborns. Glycopyrrolate is a synthetic anticholinergic agent. 19 Thiopental is a potent short-acting sedative, used for induction of anesthesia. 7 Suxamethonium is a depolarizing neuromuscular blockage agent and remifentanil a synthetic opioid, both with a rapid onset and short offset of action. 6, 8, 19 Patients and Methods 
Design
The randomization ( Figure 1A ) was performed using blocks of 4 (2:2 allocation ratio), with stratification for gestational age (GA) and postnatal age (PNA). Group allocation with drug dilution and administration regimen was provided in sealed envelopes. All investigators, medical and nursing staff, and the parents were masked as to the study group assignment.
Patients
Inclusion criteria were GA less than 37 weeks (wk) and no administration of analgesics or sedative drugs during the previous 24 h. Exclusion criteria were asphyxia (10-min Apgar score <4 or an umbilical cord pH< 7.0), serum potassium > 6 mmol/L, major malformations and postoperative care.
Study protocol
The infants were randomized to receive intravenously atropine and morphine, or the combination of glycopyrrolate, thiopental, suxamethonium and remifentanil. To counteract a blood pressure drop following drug administration, a saline infusion of 5 ml/kg was given to infants who had never 
Outcome measures
The primary outcome measure was "good intubation conditions", defined as a total intubation score of 10 or less, with all subitems scored 2 or less ( Figure 1C ). 20 Duration of the procedure, biochemical (plasma cortisol), physiological (MABP, SpO 2 , HR and rScO 2 ), behavioral (pain/stress assessment), and neurophysiological (aEEG) changes during the procedure and the subsequent 24 h were secondary outcomes.
Analyzes
We estimated achieving a 30% improvement in number of infants with "good intubation condition" using RSI. To show this difference with a significance of 5% and power of 80%, 38 infants were needed. To compensate for a 5% dropout, 40 infants should be recruited.
Physiological data were recorded at a sampling rate of 1Hz, and artifacts were manually excluded The aEEG trends were scored (EN and LHW) for continuity, sleep wake cycling, lower border of amplitude, bandwidth and the total sum of all subitems. 23 The classification was aided by inspection of the two-channel original EEG and performed in 1-h epochs for the first 6 h and for 3-h epochs thereafter.
Plasma cortisol concentrations were analyzed with a LC-MS/MS system equipped with an API 4000 triple quadrupole mass spectrometer (AB Sciex). 24 . Data were acquired and processed with the Analyst Software (Ver 1.4; AB Sciex).
Using SPSS 18.0 for Windows, Mann-Whitney, Fisher´s exact test, t-test and ANOVA were applied for statistic analyzes, as appropriate. A P-value <.05 was considered significant.
Results
In total 39 infants were randomized and 34 infants were included in the analysis, 17 in each study arm ( Figure 1A ). Of the 4 RSI infants who did not receive the allocated intervention, one infant received an accidental 10-fold overdose of thiopental 25 and was excluded from the study. Artifact-free aEEGdata were obtained for 14 infants in each group. No group differences were found at inclusion (Table1).
The primary outcome, "good intubation Volume expanders (saline, blood or plasma) were given within 2 hours prior to premedication, including three (one morphine and two RSI) infants who received a bolus saline infusion of 5 ml/kg before intubation. In total, 9 morphine and 11 RSI infants received a mean (SD) volume of 5.9 (6.0) and 7.0 (5.9) ml/kg, respectively, a non-significant difference. In ANOVA analyzes the following covariates did not change the significances in MABP and HR differences: the duration between termination of drug administration and intubation start, duration of intubation (total and for last attempt), number of attempts, volume expanders given two h before and extra doses of morphine after and additional infusions were administered to two other infants.
The neurophysiologic results differed significantly between the two interventions, with faster normalization in the RSI group and a prolonged central nervous depression in the morphine group up to 6 h after the intubation (Figure 3 ). One RSI infant had a pneumothorax and IVH after the intubation, with deterioration in EEG background activity.
Discussion
There has been increasing research interest in neonatal intubation premedication in recent years. When using a combination of several drugs, it may be difficult to separate the effects of each drug.
We consider possible differences between atropine and glycopyrrolate to be subtle or masked by the other drugs, since no previous publications indicate a difference and we did not find any HR differences after administration of the premedication. The significant group difference in procedural HR was most likely a result of optimal sedation and analgesia in RSI. However, individualized care of the infants resulted in similar rScO 2 and SpO 2 despite blood pressure decreases (Figure 2 B and C) .
Using the traditional morphine premedication, a significant increase in MABP occurred during the intubation, which might be a sign of a pain/stress reaction. This was followed by a progressive decrease in MABP for 6 h. This morphine related MAPB decrease is in agreement with recently published data. 32 In placebo controlled RCT on newborn infants, thiopental was superior with shorter procedure duration and more stable hemodynamics. 7 We have studied postnatal pharmacokinetics and pharmacodynamics of thiopental, and found it suitable even for extremely preterm infants. 25, 34 Recently propofol, a short-acting sedative, has been suggested for newborns, since it provided good intubation conditions without muscle relaxants in a RCT. 28 However, in preterm infants, significant cerebral and systemic hypotensive effects may occur. 15, 35 Remifentanil provided good intubation conditions and facilitated early extubation when used as monotherapy for INSURE, 30, 33 and was superior to morphine in a RCT. 29 No bradycardia or hypotension occurred with a dose less than 3 microg/kg. 30 As remifentanil is eliminated by nonspecific blood and tissue esterases into non-active metabolites independent of liver and renal function, it would theoretically be advantageous in preterm infants. 36 Fentanyl has a more rapid onset and a shorter duration of action than morphine, but longer duration than remifentanil. 10 Optimal premedication was reported with fentanyl in combination with muscle relaxants. 26, 27, 30, 31 There is a risk of chest wall rigidity after both fentanyl and remifentanil (3 microg/kg 30 ) and a muscle relaxant must be added.
Many new alternative relaxants are available 37 but the rapid onset, ultra-short acting suxamethonium without side effects, still justifies its role in RSI. 38 Premedication with morphine was associated with a prolonged aEEG depression throughout the follow-up period, including more delayed onset of sleep wake cycling than in the RSI group. This should be interpreted as a considerable adverse effect. Observational studies have noted that both opioids and phenobarbitone are associated with electrocortical background depression, 17, 18, 25 but no previous RCT has compared cerebral effects of morphine with those of the combination of thiopental and remifentanil.
Overall plasma cortisol levels were high in this preterm cohort 39 and the lack of significant changes in cortisol concentration to intubation can be explained by a high stress level at baseline without capacity to respond to further procedural stress/pain. The similar behavioral pain responses in both groups are probably a result of the individualized pain relief strategy, based on pain scores.
The major advantages of the RSI must be balanced against possible disadvantages of challenging drug prescription, preparation and administration with several drugs in a semi-urgent situation, recently high-lighted by Venkatesh et al.
32
. Medication errors are frequent, especially with drugs needing dilution, 25 and some could be avoided with neonatal formulations.
We aimed, in this RCT, to compare the traditional single-drug premedication with morphine to a more balanced approach with RSI. Difficulties in maintaining adequate mask ventilation in preterm patients during the required 10-15 min until peak-concentration and full effect of the morphine is of great importance and a major issue for creating other premedication strategies with short-onset drugs.
Semi-urgent intubations of preterm infants in the NICU differ from non-urgent oral intubations before neonatal surgery, as they are predominately needed for respiratory failure in stressed and even exhausted infants with immature and restrictive lung parenchyma. Intubations may be complicated and interrupted by need for suctioning and mask-ventilation. Most intubation data are based on studies conducted with oral intubations, whereas we studied nasal intubations, the routine procedure in many
NICUs. The time point of morphine administration at a minimum of 5.5 minutes prior to intubation was chosen with regard to this clinical problem, but can be considered a predictable shortcoming in addition to the case variability. The intubators, experienced neonatologists, were eight different persons that may be considered another study weakness.
An additional fluid bolus was administered to counteract a blood pressure drop, a well-known sideeffect following administration of sedatives and analgesics in other populations. Though relevant for clinical purpose, this might have altered the impact of our results, but calculations showed a nonsignificant difference in administered volume between the groups.
Experimental data suggest that anesthetic drugs might have neurodegenerative effects on the developing rodent brain, and that combinations of drugs might generate more apoptosis than single drug therapy, however thiopental is considered safe as monotherapy in mice. 40 As all RSI drugs used are short-acting, the potential risks are probably small. Current trends in neonatal pain treatment recommend a "balanced approach" 5, 10 i.e. using appropriate amounts of drugs for adequate analgesia, but never more drugs than needed.
In conclusion, this RCT showed that RSI with rapid-onset short-acting thiopental and remifentanil 
